EVOLUS, INC. Investment Income, Net
EVOLUS, INC. (EOLS) reported Investment Income, Net of $296.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2026-08-05
- EVOLUS, INC. investment income, net for the quarter ending 2026-06-30 was $296.00K, a 38.20% decline year-over-year.
- EVOLUS, INC. investment income, net for the quarter ending 2026-03-31 was $285.00K, a 59.86% decline year-over-year.
- EVOLUS, INC. investment income, net for the quarter ending 2025-12-31 was $263.00K, a 66.67% decline year-over-year.
- EVOLUS, INC. investment income, net for the quarter ending 2025-09-30 was $479.00K, a 48.38% decline year-over-year.
- EVOLUS, INC. investment income, net for fiscal 2025 was $1.93M, a 40.82% decline from fiscal 2024.
- EVOLUS, INC. investment income, net for fiscal 2024 was $3.26M, a 279.42% increase from fiscal 2023.
- EVOLUS, INC. investment income, net for fiscal 2023 was $860.00K, a 622.69% increase from fiscal 2022.
- EVOLUS, INC. investment income, net for fiscal 2022 was $119.00K, a 11800.00% increase from fiscal 2021.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $296.00K 10-Q · filed 2026-08-05 | $581.00K 10-Q · filed 2026-08-05 | $844.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.32M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $285.00K 10-Q · filed 2026-05-04 | $548.00K derived: sum of 2 quarters · filed 2026-05-04 | $1.03M derived: sum of 3 quarters · filed 2026-05-04 | $1.51M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $263.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $742.00K derived: sum of 2 quarters · filed 2026-03-03 | $1.22M derived: sum of 3 quarters · filed 2026-08-05 | $1.93M 10-K · filed 2026-03-03 |
| 2025-09-30 | $479.00K 10-Q · filed 2025-11-05 | $958.00K derived: sum of 2 quarters · filed 2026-08-05 | $1.67M 10-Q · filed 2025-11-05 | $2.46M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $479.00K 10-Q · filed 2026-08-05 | $1.19M 10-Q · filed 2026-08-05 | $1.98M derived: sum of 3 quarters · filed 2026-08-05 | $2.91M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $710.00K 10-Q · filed 2026-05-04 | $1.50M derived: sum of 2 quarters · filed 2026-05-04 | $2.43M derived: sum of 3 quarters · filed 2026-05-04 | $3.46M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $789.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $1.72M derived: sum of 2 quarters · filed 2026-03-03 | $2.75M derived: sum of 3 quarters · filed 2026-03-03 | $3.26M 10-K · filed 2026-03-03 |
| 2024-09-30 | $928.00K 10-Q · filed 2025-11-05 | $1.96M derived: sum of 2 quarters · filed 2025-11-05 | $2.47M 10-Q · filed 2025-11-05 | $2.77M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | $1.03M 10-Q · filed 2025-08-05 | $1.55M 10-Q · filed 2025-08-05 | $1.84M derived: sum of 3 quarters · filed 2026-03-03 | $2.14M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-31 | $517.00K 10-Q · filed 2025-05-07 | $808.00K derived: sum of 2 quarters · filed 2026-03-03 | $1.11M derived: sum of 3 quarters · filed 2026-03-03 | $1.28M derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-31 | $291.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $597.00K derived: sum of 2 quarters · filed 2026-03-03 | $761.00K derived: sum of 3 quarters · filed 2026-03-03 | $860.00K 10-K · filed 2026-03-03 |
| 2023-09-30 | $306.00K 10-Q · filed 2024-11-06 | $470.00K derived: sum of 2 quarters · filed 2024-11-06 | $569.00K 10-Q · filed 2024-11-06 | $646.00K derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-06-30 | $164.00K 10-Q · filed 2024-07-31 | $263.00K 10-Q · filed 2024-07-31 | $340.00K derived: sum of 3 quarters · filed 2025-03-04 | $378.00K derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-03-31 | $99.00K 10-Q · filed 2024-05-07 | $176.00K derived: sum of 2 quarters · filed 2025-03-04 | $214.00K derived: sum of 3 quarters · filed 2025-03-04 | $218.00K derived: sum of 4 quarters · filed 2025-03-04 |
| 2022-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $115.00K derived: sum of 2 quarters · filed 2025-03-04 | $119.00K derived: sum of 3 quarters · filed 2025-03-04 | $119.00K 10-K · filed 2025-03-04 |
| 2022-09-30 | $38.00K 10-Q · filed 2023-11-07 | $42.00K derived: sum of 2 quarters · filed 2023-11-07 | $42.00K 10-Q · filed 2023-11-07 | $42.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $4.00K 10-Q · filed 2023-08-02 | $4.00K 10-Q · filed 2023-08-02 | $4.00K derived: sum of 3 quarters · filed 2023-08-02 | $4.00K derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2023-05-09 | $0.00 derived: sum of 3 quarters · filed 2023-05-09 | $1.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $0.00 derived: sum of 2 quarters · filed 2023-03-08 | $1.00K derived: sum of 3 quarters · filed 2023-03-08 | $1.00K 10-K · filed 2023-03-08 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-08 | $1.00K derived: sum of 2 quarters · filed 2022-11-08 | $1.00K 10-Q · filed 2022-11-08 | $6.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $1.00K 10-Q · filed 2022-08-02 | $1.00K 10-Q · filed 2022-08-02 | $6.00K derived: sum of 3 quarters · filed 2022-08-02 | $38.00K derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-12 | $5.00K derived: sum of 2 quarters · filed 2022-03-03 | $37.00K derived: sum of 3 quarters · filed 2022-03-03 | $261.00K derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $37.00K derived: sum of 2 quarters · filed 2022-03-03 | $261.00K derived: sum of 3 quarters · filed 2022-03-03 | $635.00K 10-K · filed 2022-03-03 |
| 2020-09-30 | $32.00K 10-Q · filed 2021-11-02 | $256.00K derived: sum of 2 quarters · filed 2021-11-02 | $630.00K 10-Q · filed 2021-11-02 | $1.00M derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | $224.00K 10-Q · filed 2021-08-04 | $598.00K 10-Q · filed 2021-08-04 | $973.00K derived: sum of 3 quarters · filed 2021-08-04 | $1.43M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $374.00K 10-Q · filed 2021-05-12 | $749.00K derived: sum of 2 quarters · filed 2021-05-12 | $1.21M derived: sum of 3 quarters · filed 2021-05-12 | $1.82M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $375.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $835.00K derived: sum of 2 quarters · filed 2021-03-25 | $1.45M derived: sum of 3 quarters · filed 2021-03-25 | $1.84M 10-K · filed 2021-03-25 |
| 2019-09-30 | $460.00K 10-Q · filed 2020-10-29 | $1.07M derived: sum of 2 quarters · filed 2020-10-29 | $1.46M 10-Q · filed 2020-10-29 | $1.67M derived: sum of 4 quarters · filed 2020-10-29 |
| 2019-06-30 | $615.00K 10-Q · filed 2020-08-10 | $1.00M 10-Q · filed 2020-08-10 | $1.21M derived: sum of 3 quarters · filed 2020-08-10 | $1.21M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $389.00K 10-Q · filed 2020-05-11 | $592.00K derived: sum of 2 quarters · filed 2020-05-11 | $592.00K derived: sum of 3 quarters · filed 2020-05-11 | $592.00K derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $203.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $203.00K derived: sum of 2 quarters · filed 2020-02-25 | $203.00K derived: sum of 3 quarters · filed 2020-02-25 | $203.00K 10-K · filed 2020-02-25 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-04 | $0.00 derived: sum of 2 quarters · filed 2019-11-04 | $0.00 10-Q · filed 2019-11-04 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-12 | $0.00 10-Q · filed 2019-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |